每周股票复盘：迈得医疗（688310）Q2净利同比增2759.64%

Core Viewpoint - The stock of Maide Medical (688310) has shown significant volatility, with a recent increase in price and notable trading activity, indicating potential investor interest and market dynamics [1][2]. Trading Information Summary - Maide Medical's stock reached a closing price of 19.67 yuan as of August 29, 2025, up 6.21% from the previous week, with a peak price of 21.3 yuan on August 26, marking a near one-year high [1]. - The stock was listed on the Shanghai and Shenzhen Stock Exchanges' "Dragon and Tiger List" on August 26 due to a 15% increase in closing price, marking its first appearance in five trading days [2][6]. Shareholder Changes Summary - As of June 30, 2025, the number of shareholders for Maide Medical was 3,805, a decrease of 192 (4.8%) from March 31, 2025, with the average shareholding per account increasing from 41,600 shares to 43,700 shares [3][6]. Performance Disclosure Summary - The mid-year report for 2025 indicated a main revenue of 141 million yuan, a year-on-year decrease of 14.75%, and a net profit attributable to shareholders of 6.0451 million yuan, down 38.81% [4]. - In the second quarter of 2025, the company reported a main revenue of 101 million yuan, an increase of 10.58% year-on-year, and a net profit attributable to shareholders of 16.8424 million yuan, a significant increase of 2,759.64% [4][6]. - The company reported a debt ratio of 28.37%, with investment income of 174,600 yuan and financial expenses of -819,100 yuan, alongside a gross profit margin of 38.93% [4]. Company Announcement Summary - On August 26, 2025, Maide Medical held its fifth supervisory board meeting, where it approved the half-year report and a special report on the use of raised funds, with unanimous agreement [5][6].